Chatrin Chatrin
Impact in
- Physiology top 10%
- Calcium signaling and nucleotide metabolism
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 10
-
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 4
- Co-authors
- Lori Buetow (4 shared papers)Danny T. Huang (4 shared papers)Syed Feroj Ahmed (4 shared papers)Gary Sibbet (2 shared papers)Mads Gabrielsen (2 shared papers)Ivan Ahel (8 shared papers)Kang Zhu (7 shared papers)Dragana Ahel (7 shared papers)
- Journals
- Nucleic Acids Research (3 papers)The EMBO Journal (2 papers)eLife (2 papers)Science Advances (2 papers)Nature Communications (1 paper)
- Partner nations
- United KingdomFranceNorway
In The Last Decade
Chatrin Chatrin
12 papers receiving 282 citations
Peers
Comparison fields: 5 of 37
- Physiology 39
- Oncology 179
- Molecular Biology 191
- Immunology 49
- Epidemiology 51
Countries citing papers authored by Chatrin Chatrin
This map shows the geographic impact of Chatrin Chatrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chatrin Chatrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chatrin Chatrin more than expected).
Fields of papers citing papers by Chatrin Chatrin
This network shows the impact of papers produced by Chatrin Chatrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chatrin Chatrin. The network helps show where Chatrin Chatrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chatrin Chatrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2020 | 56 | |
| 3 | 2023 | 42 | |
| 4 | 2023 | 30 | |
| 5 | 2024 | 29 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 14 | |
| 8 | 2017 | 11 | |
| 9 | 2025 | 9 | |
| 10 | 2024 | 7 | |
| 11 | 2025 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2026 | 0 |
About Chatrin Chatrin
Chatrin Chatrin is a scholar working on Oncology, Molecular Biology, Epidemiology, Physiology and Electrical and Electronic Engineering, having authored 14 papers that have together received 284 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Ubiquitin and proteasome pathways (5 papers), Calcium signaling and nucleotide metabolism (4 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (4 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers), Genetics and Neurodevelopmental Disorders (1 paper) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Physiology (39 citations), Oncology (179 citations), Molecular Biology (191 citations), Immunology (49 citations) and Epidemiology (51 citations). Chatrin Chatrin has collaborated with scholars based in United Kingdom, France and Norway. Frequent co-authors include Lori Buetow, Danny T. Huang, Syed Feroj Ahmed, Gary Sibbet, Mads Gabrielsen, Ivan Ahel, Kang Zhu, Dragana Ahel, Brian O. Smith and Marcin J. Suskiewicz. Their work appears in journals such as Nucleic Acids Research, The EMBO Journal, eLife, Science Advances and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.